BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 9, 2009
View Archived Issues
Summit Sells Dextra Lab Unit, Now Has Funds to Stay Afloat
LONDON - Summit Corp. plc completed the life-saving divestment of its services businesses, selling its Dextra Laboratories subsidiary to New Zealand Pharmaceuticals for £950,000 (US$1.6 million). (BioWorld International)
Read More
Robust GM Crop Pipeline Could Disrupt Trade, Says EC Report
Read More
2 Broad New HIV Antibodies Found, and More are Possible
Read More
LEO Buyout Gels for Peplin: $288M, Plus Phase III Loan
Read More
Kinaris Targeting Myosins with Allosteric Inhibitors
Read More
Senexis Passes Milestone and Triggers £2.9M for Clinic Pathway
Read More
Would-be Biogen Buyer's Path Clear, Elan in Tysabri Trouble
Read More
Irish Pharma Entrepreneur Puts Wealth into Medical Research
Read More
Tioga Pauses for Japanese Deal Ahead of Asimadoline Phase III
Read More
Other News To Note
Read More